Inebilizumab for Treatment of IgG4-Related Disease

Authors: John H. Stone, Arezou Khosroshahi, Wen Zhang, Emanuel Della Torre, Kazuichi Okazaki, Yoshiya Tanaka, J. Matthias Löhr, Nicolas Schleinitz, Lingli Dong, Hisanori Umehara, Marco Lanzillotta, Zachary S. Wallace, Mikael Ebbo, George J. Webster, Fernando Martinez Valle, Manu K. Nayar, Cory A. Perugino, Vinciane Rebours, Xinxin Dong, Yanping Wu, Qing Li, Nishi Rampal, Daniel Cimbora, Emma L. Culver

Published: 2024-11-14

DOI: 10.1056/nejmoa2409712

Source: Full article


Abstract

No abstract found.